VAERS Explorer
Back to explore

Report #2826134

Received Feb 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
50 yrs
State
—
Recovered
Unknown
Vaccinated
Jan 16, 2025
Onset
Jan 17, 2025
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNKRA

Symptoms (2)

Influenza like illnessPyrexia

Symptom narrative

Flu like symtoms/fever; This non-serious case was reported by a consumer via sales rep and described the occurrence of influenza-like symptoms in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 16-JAN-2025, the patient received Shingrix (right arm). On 17-JAN-2025, 1 days after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: Flu like symtoms/fever). The outcome of the influenza-like symptoms was unknown. The reporter considered the influenza-like symptoms to be related to Shingrix. The company considered the influenza-like symptoms to be related to Shingrix. Additional Information: GSK Receipt Date: 17-JAN-2025 Patient received Shingrix and experienced fever of 101.2 and flu like symptoms.

Lab data

Test Date: 20250117; Test Name: body temperature; Result Unstructured Data: (Test Result:101.2,Unit:degree F,Normal Low:,Normal High:)